2014
DOI: 10.1158/1940-6207.capr-14-0124
|View full text |Cite
|
Sign up to set email alerts
|

Laboratory to Community: Chemoprevention Is the Answer

Abstract: In the current issue, Johnson and colleagues present exciting results, using biomarkers involved in aflatoxin B 1 (AFB 1 )-induced hepatocarcinogenesis, as an example of a conceptual framework to target mechanisms of action in developing chemopreventive agents. Their innovative approach offers considerable promise for a field that has long been neglected. Proof-of-principle was demonstrated using a synthetic triterpenoid (CDDO-Im), which activates Nrf2 signal transduction pathway, inhibits formation of AFB 1 -… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2016
2016
2019
2019

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 28 publications
(33 reference statements)
0
5
0
Order By: Relevance
“…However, as adducts do not equal mutations, there are several additional necessary key events proposed that require functioning cellular responses such DNA replication and cell division, prior to causing a mutation. Thus, formation of adducts, even pro-mutagenic ones, will not necessarily guarantee a mutagenic outcome [66, 67]. …”
Section: Alkylating Agentsmentioning
confidence: 99%
“…However, as adducts do not equal mutations, there are several additional necessary key events proposed that require functioning cellular responses such DNA replication and cell division, prior to causing a mutation. Thus, formation of adducts, even pro-mutagenic ones, will not necessarily guarantee a mutagenic outcome [66, 67]. …”
Section: Alkylating Agentsmentioning
confidence: 99%
“…They argue that due to the complex mechanism of the Nrf2/Keap1/ARE signaling pathways that mediate CDDO-Im anti-tumorigenicity may activate other cellular processes, e.g., as inflammation, that eliminate or interfere with the progression and promotion of initiated cells resulting in an "apparent" threshold, which may not be valid for chronic exposure to very low doses of AFB1 in the absence of CDDO-Im. On the contrary, Olden and Vulimiri [201] supported the arguments given by…”
Section: Natural and Socioeconomic Challengesmentioning
confidence: 82%
“…The study has attracted wide interest from peer scientists with both admiration and criticism not only for its rational experimental design and for providing an additional proof-of-principal for the high potency of CDDO-Im and potential to ensure complete protection against CCH, but also for reviving the debate on the "no-threshold/linear" vs "threshold/non-linear" dose-response paradigms in quantitative risk assessment of genotoxic hazards. Nonetheless, the claim about the non-linear dose-response relationship at very low doses and the applicability of the results to humans have raised some reservations [200][201] recognizing the valuable contribution of the study to the advance of knowledge in the field, Eaton…”
Section: Natural and Socioeconomic Challengesmentioning
confidence: 99%
“…They argue that the complex mechanism of the Nrf2/Keap1/ARE signaling pathways that mediate CDDO-Im anti-tumorigenicity may also activate other cellular processes, e.g., anti-inflammation, and eliminate or interfere with the progression and promotion of initiated cells resulting in an “apparent” threshold, which may not be valid for chronic exposure to very low doses of AFB1 in the absence of CDDO-Im. On the contrary, Olden and Vulimiri [201] supported the arguments given by Johnson, Egner, Baxter [196] for the non-linearity of the dose-response relationship. Moreover, Eaton and Schaupp [200] questioned the putative chemoprotective efficacy of CDDO-Im in humans as was demonstrated in rats.…”
Section: Challenges and Prospects For Aflatoxin Researchmentioning
confidence: 85%
“…The study has attracted wide interest from peer scientists with both admiration and criticism not only for its rational experimental design and for providing an additional proof-of-principal for the high potency of CDDO-Im and potential to ensure complete protection against CCH, but also for reviving the debate on the “no-threshold/linear” vs. “threshold/non-linear” dose-response paradigms in quantitative risk assessment of genotoxic hazards. Nonetheless, the claim about the non-linear dose-response relationship at very low doses and the applicability of the results to humans have raised some reservations [200,201]. While recognizing the valuable contribution of the study to the advance of knowledge in the field, Eaton and Schaupp [200] scrutinize the study and expressed skepticism about some interpretations.…”
Section: Challenges and Prospects For Aflatoxin Researchmentioning
confidence: 99%